Curexa Pharmacy

What Curexa Pharmacy does

Curexa Pharmacy (legal entity EHT Pharmacy LLC) is a US-based, family-founded 503A compounding pharmacy operating since 2003 from Egg Harbor Township, New Jersey, with additional sites in Galloway, New Jersey and Gilbert, Arizona. The company compounds patient-specific customized medications — including suppositories, topical formulations, troches, creams and ointments, and capsules — often formulated to exclude problem-causing excipients such as dyes, sugar, lactose, alcohol, gluten, or preservatives, and complements compounding with traditional retail dispensing, manufacturer packaging and labeling services, and collaborative research and development for clinical formulations. Its technology foundation is an API-connected platform that integrates electronically with partner systems for prescription management and fulfillment, supporting nationwide shipping across all 50 US states alongside local pick-up and delivery.

The business model is B2B and transaction-fee based: Curexa generates revenue per compounded prescription, per dispensed prescription, and per packaging/labeling engagement, with pricing quoted per formulation rather than published. Its customer base is segmented across five verticals — telemedicine providers (positioned as the primary segment), medical providers, veterinary providers, pharmaceutical manufacturers, and clinical research organizations — served through consultative partnership sales, API integration, and accreditation-driven trust signals (503A designation, PCAB Accreditation, URAC Specialty Pharmacy Accreditation, and LegitScript Certification).

Since December 2021, the company has operated under private equity sponsorship led by Pouschine Cook Capital Management (with ORIX Capital Solutions and Hexagon as co-investors and First Horizon Bank as senior lender); co-founder Mark Taylor remains President and CEO, John Pouschine serves as Chairman, and recent senior additions include former FDA Principal Deputy Commissioner Rachel Sherman on the Board (March 2023) and Robert Cimorelli as SVP of Regulatory and Strategic Operations (February 2024). A January 2026 strategic partnership and licensing agreement with Pete Pharma extends the model from contract compounding toward proprietary, co-developed compounded products.

Name

Curexa Pharmacy

Legal name

EHT Pharmacy LLC

Website

https://curexa.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Curexa Pharmacy is a US-based 503A compounding pharmacy founded in 2003 that uses API-connected technology to dispense customized medications nationwide for telemedicine providers, medical providers, veterinarians, manufacturers, and clinical research organizations.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

akta.pro secondary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Compounding pharmacy services
• 503A pharmaceutical compounding
• Telemedicine pharmacy fulfillment
• Veterinary compounding services
• Specialty pharmacy solutions

Headquarters

HQ city

Egg Harbor Township

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Compounding Pharmacy Services: Revenue generated from customized pharmaceutical compounding services for patients whose prescriptions are not commercially available. Services include various dosage forms such as suppositories, topical formulations, troches, creams, ointments, and capsules. The company serves telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations nationwide.
2. Traditional Dispensary Services: Traditional prescription dispensing services offering common pharmaceutical medications for both humans and pets with multiple shipping options. Includes retail, specialty, and compounding pharmacy services with local pick-up, local delivery, and nationwide shipping.
3. Packaging and Labeling Services: Pharmaceutical packaging and labeling services for manufacturers including inventory management and administrative support. API connectivity and seamless integration into clients' systems ensure reliability and responsiveness.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Curexa Pharmacy is an API-connected 503A compounding pharmacy that produces customized pharmaceutical medications not commercially available, including multiple dosage forms such as suppositories, topicals, troches, creams, ointments, and capsules. The company also provides traditional prescription dispensary services, packaging and labeling for manufacturers, and collaborative research and development for clinical organizations. Services are delivered to telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations across all 50 U.S. states.

Product overview

Curexa Pharmacy is an independent, family-owned pharmacy founded in 2003 offering a unified portfolio of pharmaceutical services centered on 503A compounding pharmacy capabilities. The core offering combines pharmaceutical compounding services (suppositories, topical formulations, troches, creams/ointments, capsules) with traditional dispensary services, research and development, and packaging/labeling solutions. Services are delivered to telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations nationwide through API-connected technology infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Compounding Services Customized medication compounding creating prescriptions not commercially available, with 503A designation allowing medications free of problem-causing excipients such as dyes, sugar, lactose, alcohol, gluten, or preservatives. Serves telemedicine, medical, and veterinary providers, manufacturers, and clinical research organizations nationwide.
• Traditional Dispensary Services Retail pharmacy dispensing services for common pharmaceutical medications for humans and pets, with multiple shipping options including local pick-up, local delivery, and nationwide shipping with discreet packaging.
• Research and Development Services

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Pete PharmacoreStrategic or Co-development Partner · 27 January 2026Strategic partnership designed to support Curexa's growth through access to Pete Pharma's intellectual property, formulation expertise, and scalable product development infrastructure. Includes a definitive licensing agreement under which Pete Pharma will support Curexa in the research, development, and commercialization of proprietary compounded products.
• McDermott Will & Emery LLPminorOthers · 1 November 2021Legal advisor to the buyer group in the Curexa investment transaction led by Pouschine Cook Capital.
• Covington AssociatesminorOthers · 1 November 2021Served as exclusive financial advisor to Curexa in the Pouschine Cook investment transaction.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• KlaraScript Pharmacy: Tech-forward compounding pharmacy offering API and digital tools for telehealth providers. Comparable to Curexa's API-first positioning, though smaller in scale and more narrowly focused on telehealth integrations.

Direct peers

• Wedgewood Pharmacy: Specialty compounding pharmacy with one of the largest veterinary compounding practices in the U.S. Directly comparable to Curexa's veterinary compounding segment and broader 503A compounding model, with PE backing from Welsh Carson.
• Empower Pharmacy: One of the largest 503A and 503B compounding pharmacies in the U.S., serving telehealth providers, medical practices, and patients nationwide. Directly comparable to Curexa in regulatory designation, telehealth-partner GTM, and national-scale 503A compounding focus.
• US Compounding Pharmacy: 503A compounding pharmacy offering customized preparations for humans and animals. Directly comparable to Curexa's core 503A compounding services and nationwide shipping model for provider-partnered prescriptions.
• Boothwyn Pharmacy: 503A compounding pharmacy serving physicians and patients with customized medications. Comparable to Curexa as a Pennsylvania-based 503A compounding peer serving medical providers; Robert Cimorelli (Curexa's SVP Regulatory) previously worked here.
• Precision Compounding Pharmacy: 503A compounding pharmacy serving medical providers and patients with customized formulations across hormone therapy, dermatology, and other specialties. Comparable to Curexa's compounding dosage forms (topicals, capsules, troches) and provider partnership model.
• Diamondback Drugs: Veterinary-focused compounding pharmacy serving veterinarians with customized formulations. Directly comparable to Curexa's veterinary compounding service line and its emphasis on flavored and transdermal preparations for pets and exotics.

Broad incumbents

• BioPlus Specialty Pharmacy: Specialty pharmacy providing compounding and specialty therapies for chronic and complex conditions. Comparable as an accredited specialty pharmacy with national provider relationships, though broader in therapeutic scope than Curexa.
• Pentec Health: Specialty pharmacy and compounding services provider focused on complex patient populations including intrathecal and parenteral nutrition. Comparable to Curexa as a specialized pharmacy services provider; Robert Cimorelli (Curexa SVP Regulatory) previously held a role here.
• Avella Specialty Pharmacy: URAC-accredited specialty pharmacy with broad therapeutic and compounding capabilities, now part of Optum Specialty Pharmacy. Comparable to Curexa as a nationally accredited specialty/compounding pharmacy serving provider networks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/jerseyshorerx

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curexa Pharmacy